China SXT Pharmaceuticals, Inc. (SXTC)
| Market Cap | 35.55M |
| Revenue (ttm) | 1.25M |
| Net Income (ttm) | -6.56M |
| Shares Out | 18.51M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $1.92 |
| Previous Close | $2.08 |
| Change ($) | -0.16 |
| Change (%) | -7.69% |
| Day's Open | 2.02 |
| Day's Range | 1.90 - 2.12 |
| Day's Volume | 860,754 |
| 52-Week Range | 0.89 - 5.12 |
News
TAIZHOU, China, Feb. 19, 2021 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, develo...
About SXTC
China SXT Pharmaceuticals, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. A... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jan 4, 2019 |
| CEO Feng Zhou | Employees 97 |
| Stock Exchange NASDAQ | Ticker Symbol SXTC |